Clinical and molecular features predicting long-term response (LTR) to anti-PD-(L)1 based therapy in patients with NSCLC Meeting Abstract
| Authors: | Rizvi, H.; Plodkowski, A. J.; Tenet, M.; Halpenny, D.; Long, N.; Sauter, J. L.; Sanchez-Vega, F.; Chatila, W. K.; Schultz, N.; Ladanyi, M.; Arbour, K. C.; Chaft, J. E.; Hellmann, M. D. |
| Abstract Title: | Clinical and molecular features predicting long-term response (LTR) to anti-PD-(L)1 based therapy in patients with NSCLC |
| Meeting Title: | 54th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 36 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2018 Jun 1-5 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2018-05-20 |
| Start Page: | 465s |
| Language: | English |
| ACCESSION: | WOS:000442916003196 |
| DOI: | 10.1200/JCO.2018.36.15_suppl.9022 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 9022 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
